Skip to main content
Journal of Histochemistry and Cytochemistry logoLink to Journal of Histochemistry and Cytochemistry
. 2020 Nov 20;69(1):49–60. doi: 10.1369/0022155420973980

Heparan Sulfate Biosynthesis in Zebrafish

Beata Filipek-Górniok 1,*, Judith Habicher 2,*, Johan Ledin 3, Lena Kjellén 4,
Editors: Liliana Schaefer, Charles W Frevert
PMCID: PMC7780192  PMID: 33216642

Abstract

The biosynthesis of heparan sulfate (HS) proteoglycans occurs in the Golgi compartment of cells and will determine the sulfation pattern of HS chains, which in turn will have a large impact on the biological activity of the proteoglycans. Earlier studies in mice have demonstrated the importance of HS for embryonic development. In this review, the enzymes participating in zebrafish HS biosynthesis, along with a description of enzyme mutants available for functional studies, are presented. The consequences of the zebrafish genome duplication and maternal transcript contribution are briefly discussed as are the possibilities of CRISPR/Cas9 methodologies to use the zebrafish model system for studies of biosynthesis as well as proteoglycan biology.

Keywords: extracellular matrix, glycosaminoglycan, glycosyltransferase, proteoglycan, sulfotransferase

Introduction

The diverse family of proteoglycans contains proteins substituted with one to more than hundred sulfated glycosaminoglycan chains, linear polysaccharides built up of repeating disaccharide units.1,2 The glycosaminoglycans found in proteoglycans include chondroitin sulfate (CS), dermatan sulfate (DS), keratan sulfate, heparan sulfate (HS), and heparin. Interestingly, although the majority of vertebrate proteins are glycoproteins, less than 100 proteins have been identified as proteoglycan core proteins.3 The HS proteoglycans, which is the subject of this review (see Fig. 1), are present on the cell surface of most, if not all, vertebrate cells. In addition, HS proteoglycans are found in the extracellular matrix, particularly abundant in basement membranes.4,5 Heparin, with the same sugar backbone as HS but with a higher degree of sulfation, is found in mast cell granules.6

Figure 1.

Figure 1.

Heparan sulfate proteoglycans. Syndecans and glypicans are cell surface proteoglycans, whereas agrin and perlecan are present in the basement membranes. Serglycin with heparin chains is stored in mast cell granules.

The biological functions of HS proteoglycans rely, to a large extent, on interactions with proteins, where HS binding will modulate their functions.7 The sulfation pattern of the HS chain will determine affinity for the protein ligands and is thus essential for function. The nature of the core protein and its level of expression will also affect HS function by influencing, for example, the localization of the HS chains (cell surface vs extracellular matrix) and the concentration of HS in these locations. During embryonic development, the abilities of heparan sulfate proteoglycans to act as coreceptors and to participate in the generation and maintenance of morphogen gradients are essential. Mouse embryos lacking HS die early during development, that is, at the time of gastrulation.8

The sulfation pattern of HS is determined during biosynthesis in the Golgi compartment9; however, extracellular editing by SULF 6-O-sulfatases will also change the HS structure after biosynthesis.10 These enzymes, two in mammals and three in zebrafish (Sulf1, Sulf2a, Sulf2b),11 will act on highly sulfated regions of the HS chain, removing 6-O-sulfate groups and thereby altering the affinity for several growth factors.10

Zebrafish belongs to the ray-finned fishes (infraclass Teleostei) and has several advantages as a model organism. However, due to a whole-genome duplication in teleost fish, the number of genes encoding biosynthesis enzymes and proteoglycan core proteins are larger than in other vertebrates.12 Although the expression of one of the duplicated genes may be lost (non-functionalization), both copies may be retained with similar or novel functions. The increased number of genes important for HS biosynthesis complicates studies in zebrafish. However, some of these genes have been non-functionalized (see Fig. 2 and below). Most of what we know about HS and heparin biosynthesis has been learnt in studies of rats and mice, in vivo and in cell cultures and also in cell-free systems with recombinant enzymes.9,1315 However, there is no reason to believe that the basic mechanisms would be different in zebrafish, in particular because the structural features of zebrafish HS are similar to those of mammalian HS.16,17

Figure 2.

Figure 2.

Polymerization and modification reactions during HS biosynthesis. After synthesis of the linkage region (see Fig. 3), the first HS-specific glycosyltransferase Ext13 adds a GlcNAc residue, followed by alternating additions of GlcA and GlcNAc by the HS copolymerase composed of one Ext1 (a, b, or c) and one Ext2 subunit. Note the dependence of UDP-sugars for these steps and the requirement for the sulfate donor PAPS for the following sulfation reactions. As the chain is growing, one or more of the bifunctional Ndst enzymes replace N-acetyl groups of selected GlcNAc residues with N-sulfate groups. Then follows C5-epimerization of GlcA residues into IdoA by Glce (a or b). This reaction occurs close to newly N-sulfated glucosamine residues, and the IdoA residues are the preferred substrate of the HS 2-O-sulfotransferases (1a or 1b). Then follows 6-O-sulfation by Hs6st enzymes (1a or 1b, 2, 3a or 3b) and 3-O-sulfation by one or more of the nine 3-O-sulfotransferases. Abbreviations: HS, heparan sulfate; GlcNAc, N-acetylglucosamine; GlcA, glucuronic acid; PAPS, 3′-phosphosadenosine-5′-phosphosulfate; IdoA, iduronic acid; NS, N-sulfate group; UDP, uridine diphosphate.

It Starts With a Core Protein

HS is synthesized in the Golgi compartment, where the growing HS chains are attached to serine residues in selected proteins. The major cell surface HS proteoglycans are syndecans and glypicans (see Fig. 1). Although the 6 mammalian glypican genes are paralleled by 10 zebrafish genes,18 only three zebrafish syndecans have been identified compared with four in mammals. Among the extracellular matrix proteoglycans, single genes for perlecan and agrin are present in both mammalian and zebrafish genomes,19,20 whereas the two copies of the duplicated zebrafish collagen18a1 genes are expressed.21 Serglycin, the core protein which in mammals carries heparin chains, is encoded by single genes both in zebrafish22 and in mammals. The expression of core proteins will influence the location and amounts of HS and thereby affect the functional properties of the proteoglycans. Although the structure of HS primarily seems to depend on the type of cell responsible for biosynthesis, it has also been reported that the core protein may influence the outcome of biosynthesis.23,24

. . . and Biosynthesis of a Linkage Region

One or more serine residues in the core protein will serve as acceptor for the first sugar of the linkage region, a xylose, added by a xylosyltransferase (see Table 1 for enzymes participating in HS biosynthesis). Although the serine residue almost always is followed by a glycine, a consensus sequence for GAG attachment has so far not been possible to define. After xylosylation, two galactose residues, one at a time, will be transferred by two different galactosyltransferases. The fourth sugar, a glucuronic acid (GlcA), completes the linkage region. The same tetrasaccharide also functions as a linkage region in the biosynthesis of the glycosaminoglycans CS and DS. The galactose-xylose disaccharide residue can be transiently phosphorylated by Fam20b kinase, and the galactose units, at least in CS/DS GAG chains, may also be sulfated.25 Although the role of sulfation is unclear, the transient phosphorylation of xylose appears to be essential for both HS and CS/DS chain elongation.26,27 A phosphatase removing the phosphate group on xylose has also been identified.28 Zebrafish mutants for several of the enzymes taking part in the biosynthesis of the linkage region are available (see Table 2 and Fig. 3). Their phenotypes will reflect altered biosynthesis of both HS and CS/DS.

Table 1.

Genes Encoding Human and Zebrafish Heparan Sulfate Biosynthesis Enzymes.

Human Gene and Gene Symbol Zebrafish Gene Symbol (Previously Used Gene Symbol)
Linkage region synthesis
 Xylosyltransferase 1, XYLT1
 Xylosyltransferase 2, XYLT2
xylt1
xylt2
 Beta-1,4-galactosyltransferase 7, B4GALT7 b4galt7
 Beta-1,3-galactosyltransferase 6, B3GALT6 b3galt6
 Beta-1,3- glucuronyltransferase 3, B3GAT3 b3gat3
 FAM20B glycosaminoglycan xylosylkinase, FAM20B fam20b
 2-phosphoxylose phosphatase 1, PXYLP1 pxylp1
Committed step, elongation
 Exostosin-like glycosyltransferase 3, EXTL3 ext13 (boxer)
 Exostosin glycosyltransferase 1, EXT1 ext1a
ext1b
ext1c
 Exostosin glycosyltransferase 2, EXT2 ext2 (ext2a, dackel)
 Exostosin-like glycosyltransferase 2, EXTL2 ext12
Modification
N-deacetylase/N-sulfotransferase 1, NDST1
N-deacetylase/N-sulfotransferase 2, NDST2
N-deacetylase/N-sulfotransferase 3, NDST3
N-deacetylase/N-sulfotransferase 4, NDST4
ndst1a
ndst1b (ndst1)
ndst2a
ndst2b (ndst2)
ndst3
 Glucuronic acid epimerase, GLCE glcea
glceb
 Heparan sulfate 2-O-sulfotransferase 1, HS2ST1 hs2st1a (hs2st1)
hs2st1b
 Heparan sulfate 6-O-sulfotransferase 1, HS6ST1
 Heparan sulfate 6-O-sulfotransferase 2, HS6ST2
 Heparan sulfate 6-O-sulfotransferase 3, HS6ST3
hs6st1a (6-ost-1a)
hs6st1b (6-ost-1b)
hs6st2 (hs6st)
hs6st3a
hs6st3b (6-ost-3)
 Heparan sulfate-glucosamine 3-sulfotransferase 1, HS3ST1
 Heparan sulfate-glucosamine 3-sulfotransferase 2, HS3ST2
 Heparan sulfate-glucosamine 3-sulfotransferase 3A1, HS3ST3A1
 Heparan sulfate-glucosamine 3-sulfotransferase 3B1, HS3ST3B1
 Heparan sulfate-glucosamine 3-sulfotransferase 4, HS3ST4
 Heparan sulfate-glucosamine 3-sulfotransferase 5, HS3ST5
 Heparan sulfate-glucosamine 3-sulfotransferase 6, HS3ST6
hs3stl (3-ost-1, zf3-ost-1)
hs3st1l1 (3-ost-7, zf3-ost-7)
hs3st1l2 (3-ost-5, zf3-ost-5)
hs3st2 (3-ost-2, zf3-ost2)
si: dkey-121b10.7a
hs3st3b1a (3-ost-3x, zf3-ost-3x)
hs3st3b1b (3-ost-3z, zf3-ost-3z)
hs3st4 (3-ost-4, zf3-ost4)


hs3st3l (3-ost-6, zf3-ost-6)

Source. NCBI (National Center for Biotechnology Information)/ZFIN (The Zebrafish Information Network).

a

Equally similar to hs3st3a1 and hs3st3b1.

Table 2.

Glycosaminoglycan Mutants.

Human Gene Symbol/Protein Name Human Disease/OMIM # (H)
Mouse Mutant and Phenotype (M)
Zebrafish Mutant Gene Symbol and Phenotype
SLC35B2
3′-phosphoadenosine 5′-phosphosulfate (PAPS) transporter 1
slc35b2−/−
Cartilage defects29
UGDH
UDP-glucose dehydrogenase
H: Developmental epileptic encephalopathy30
M: Embryonic lethality, gastrulation failure31
ugdh1−/−
Cardiac valve formation, defective CNS patterning, axial morphogenesis, left-right pattern formation32,33
UXS1
UDP-glucuronate decarboxylase 1
M: Prenatal death.34 uxs1−/−
Craniofacial cartilage and bone defects, shorter pectoral fins35
FAM20B
Glycosaminoglycan xylosylkinase
H: Neonatal short limb dysplasia36 M: Embryonic lethality at E13.5, multisystem organ hypoplasia37
Annulus fibrosus developmental defects38
fam20b−/−
Cartilage defect39
XYLT1
Xylosyltransferase 1
H: Desbuquois dysplasia type 240 xylt1−/−
Cartilage defects39
B4GALT7
β-1,4-galactosyl-transferase 7
H: Spondylodisplastic Ehlers-Danlos syndrome41 b4galt7−/−
Cartilage defects42,43
Ehlers-Danlos-like syndrome44
B3GAT3
β-1,3-Glucuronyl-transferase 3
H: Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects/#245600 b3gat3−/−
Craniofacial cartilage defects, shorter pectoral fins42,45
EXTL3
Exostosin-like glycosyltransferase 3
M: Embryonic lethal at E9.46 extl3−/−
Craniofacial cartilage defects, shorter pectoral fins16,29,47
EXT2
Exostosin glycosyltransferase 2
H: Hereditary multiple exostoses type2/#133701
M: Mutants—gastrulation failure, embryonic lethality at E6–7.5. Heterozygous adults show skeleton abnormalities48
ext2−/−
Defects in craniofacial cartilage, axon sorting, tooth development, lack of pectoral fins16,17,29,49

ONIM indicates Online Mendelian Inheritance in Man; CNS, central nervous system; UDP, uridine diphosphate.

Figure 3.

Figure 3.

Glycosaminoglycan mutants. Most of the zebrafish glycosaminoglycan mutants affect biosynthesis of the common HS and CS/DS linkage region (shaded in the Figure). XYLT1 is one of the two xylosyltransferases adding xylose to selected serine residues in the core protein. Phosphorylation of xylose is carried out by Fam20b, for which a mutant is available. This is also the case for the enzymes responsible for the synthesis of UDP-xylose (Uxs1) and its precursor UDP-GlcA (Ugdh). Lack of UDP-GlcA will also affect polymerization of the glycosaminoglycan chains (see Fig. 2). Mutants are also available for two of the three enzymes completing the linkage region, B4galt7 adding the first galactose unit, and B3gat3 adding the fourth sugar, a GlcA. The two HS-specific enzymes for which mutants are available are Ext13 and Ext2, affecting HS polymerization (see Fig. 1). The ninth mutant affects transport by Papst1 of the sulfate donor PAPS into the Golgi compartment. Enzymes for which mutants have been isolated are placed within ellipses. Abbreviations: HS, heparan sulfate; CS, chondroitin sulfate; DS, dermatan sulfate; GlcA, glucuronic acid; PAPS, 3′-phosphosadenosine-5′-phosphosulfate; GlcNAc, N-acetylglucosamine; UDP, uridine diphosphate glucose.

. . . Followed by a Committed Step

Although most GAG attachment sites are specific for HS or CS/DS, respectively, some are not; an example is serglycin which in many cells is a CS proteoglycan, but in connective tissue–type mast cells it is substituted with heparin chains6; another example is perlecan where the C-terminal GAG attachment site can be substituted with either HS or CS.50 However, transfer of an N-acetylglucosamine (GlcNAc) residue to the tetrasaccharide linkage region by the exostosin-like glycosyl transferase 3 (Extl3) will commit the biosynthesis to HS (or heparin). Accordingly, HS amounts are reduced in extl3 mutant zebrafish larvae,16,17 discussed further below.

Elongation and Modification Occur Together

The HS chain is polymerized through alternating transfer of GlcA and GlcNAc by the HS copolymerase composed of exostosin glycosyltransferase 1 and 2 (Ext1/Ext2). At the same time as the chain is growing, it is modified, the first modification being N-deacetylation followed by N-sulfation of GlcNAc residues. Most subsequent modifications occur in N-sulfated regions of the GAG chain and starts with epimerization of GlcA into iduronic acid (IdoA), followed by 2-O-sulfation of IdoA. After epimerization and 2-O-sulfation follow 6-O-sulfation and 3-O-sulfation of GlcNAc and its N-sulfated counterpart (see Fig. 2). All sulfation reactions rely on the presence of the universal sulfate donor 3′-phosphosadenosine-5′-phosphosulfate (PAPS).

Multiple Zebrafish Enzymes

Although the zebrafish genome contains a single ext2 gene, three ext1 orthologs have been identified (see Table 1). As efficient polymerization of HS requires both Ext1 and Ext2, the single Ext2 would be expected to be necessary for HS biosynthesis. Interestingly, an ext2 mutant is available with multiple severe phenotypes (see below, Table 2 and Fig. 4). In mice, gene knockouts of Ext2 and Ext1 are lethal.8,48 Maternal mRNA contribution is most likely the reason why the phenotype is milder in the zebrafish mutants. In addition to Ext1, Ext2, and Extl3, a fourth glycosyltransferase, Extl2, may also affect HS biosynthesis. Mice lacking this glycosyl transferase are viable and fertile,51 but this enzyme has not been studied in zebrafish.

Figure 4.

Figure 4.

Pharyngeal cartilage morphology. Many zebrafish proteoglycan mutants develop malformations in the pharyngeal cartilage. Schematics of control larvae at 5 (A) and 6 (B) dpf give an overview of the organization of the pharyngeal cartilage elements seen in the ventral views of Tg(−1.7col2a1a:EGFP-CAAX) control larvae (C, D). uxs1−/− (E, G) and ext2−/− (F, H) larvae have disrupted intercalation of chondrocytes, resulting in abnormal-shaped pharyngeal cartilage elements. In addition, ext2−/ larvae lack pectoral fins (*).Scale bar, 100 µm. Abbreviations: m, Meckel’s cartilage; pq, paloquadrate; hs, hyosymplectic; bh, basohyal; c, ceratohyal; dpf, days post fertilization.

Bifunctional Ndst (N-deactylase/N-sulfotransferase) enzymes, five in zebrafish52 (see Table 1), will form N-sulfated domains on the growing HS chain. Of the five, two are Ndst1 orthologs and two are Ndst2 orthologs. The fifth zebrafish ndst (ndst3) is most likely an ortholog of the Ndst gene that in mammals through a local gene duplication gave rise to Ndst3 and Ndst4.52 All ndst transcripts are maternally contributed and widely expressed, the spinal cord being an exception; here, only ndst3 transcript could be detected.52

The single mammalian C5-epimerase (Glce) and 2-O-sulfotransferase each have two orthologs in zebrafish.53 Five zebrafish 6-O-sulfotransferase and nine 3-O-sulfotransferase genes have been identified in the zebrafish genome compared with three and seven in mammals.54,55 Although the distribution of the modification enzymes (sulfotransferases and epimerases) has been studied on the transcript level,5255 little is known about the contribution of the different isoforms to HS synthesis or their enzymatic characteristics. Some HS biosynthesis enzymes, for example, Ext2 and Extl3, are ubiquitously expressed in most tissues during zebrafish embryo development,16 whereas others, such as members of the 3-O-sulfotransferase family, show a distinct spatial and temporal expression.55 Enzymes with such regulated expression could possibly have instructive functions for HS, changing the affinities of the polysaccharide for binding proteins.

Glycosaminoglycan Biosynthesis Mutants

Forward genetic screens where mutagens have been used to randomly introduce mutations in the zebrafish genome have been one way of linking specific genes to their function. In this manner, nine genetic mutants with defective biosynthesis of glycosaminoglycans have been identified (Fig. 3 and Table 2; see Habicher et al.56). Slc35b2 is one of the two transporters of the sulfate donor PAPS from the cytoplasm into the Golgi compartment, affecting all sulfation reactions in this organelle; uridine diphosphate glucose (UDP)-glucose dehydrogenase (Ugdh) converts UDP-glucose into UDP-GlcA, needed for the biosynthesis of sulfated glycosaminoglycans and hyaluronan, possibly affecting also detoxification reactions in the liver; UDP-glucuronate decarboxylase 1 (Uxs1) makes UDP-xylose from UDP-GlcA necessary for the biosynthesis of the shared HS and CS/DS linkage region. Synthesis of the linkage region will also be affected by the four mutants fam20b, xylt1, b4galt7, and b3gat3. Cartilage defects and in particular abnormal jaw and pharyngeal cartilage structures (see Fig. 4) are phenotypes strikingly consistent in all identified mutants affecting both HS and CS/DS biosynthesis (Table 2).

Finally, ext2 and extl3 mutations will directly influence HS biosynthesis only. These two mutants show reduced pectoral fins,57 deformed pharyngeal cartilage17 (Fig. 4), defective sorting of axons in the optical tract,16 and defective thymopoiesis.58 Interestingly, although the defects are qualitatively similar, the phenotypes are more severe in the ext2 mutant, possibly caused by lower amounts of maternal ext2 mRNA in the early embryonic stage. When examined 6 days post fertilization (dpf), HS levels were reduced in both mutants; the reduction was most pronounced in the ext2 mutant which contained less than 20% of the control levels.17 The low levels of HS synthesized were highly modified in both mutants, possibly reflecting a higher ratio of HS modification enzymes relative to the available HS polysaccharide substrate. Interestingly, extl3 mutants contained elevated levels of CS,17 tentatively as a result of a compensatory mechanism to replace the lost HS. This phenomenon has also been documented in HS-deficient CHO-cells and in embryonic stem cells with altered HS production, and also in vivo in cartilage of mouse embryos with defective HS biosynthesis.8,5961 A similar increase in CS amounts was not seen in the ext2 mutant, and it was speculated that the “committed step,” glycosyltransferases adding GlcNAc for HS (Extl3) or GalNAc for CS biosynthesis, could be critical in determining HS and CS/DS amounts. The more severe cartilage phenotype of the ext2 than the extl3 mutant could be another explanation.

Future Perspective

Much is yet to be known about HS biosynthesis, and the zebrafish model system will be a powerful tool in these studies. In addition to studies of mutants, morpholino knockdown experiments blocking either translation or splicing of specific genes have previously been used to give valuable information about gene function. However, usage of morpholinos has been linked to unspecific upregulation of the p53 pathway, leading to increased levels of apoptotic neural death and defects within craniofacial cartilage.62 The more recent CRISPR/Cas9 technology has now provided the genome engineering field with an efficient tool for generating targeted mutations.63 The method is based on the usage of a guide RNA (gRNA) and the Cas9 endonuclease complex introducing a double-stranded break at the site of gRNA base pairing to the genomic DNA. Non-homologous end joining (NHEJ), a genomic DNA repair system prone to mistakes, frequently causes frameshift mutations, leading to loss-of-function of the targeted genes. The CRISPR/Cas9 technologies further open up for virtually endless possibilities for studies of “humanized” transgenic zebrafish (i.e., where mutations similar to human patients are introduced) and to tag and exogenously express enzymes to monitor phenotypic changes. In addition, the technique is increasingly used for specific labeling of distinct cell types by the expression of fluorescent proteins and genetic fingerprints, which significantly increases our ability to detect phenotypic changes of HS mutants.

Comparisons of CRISPR/Cas9 knockout phenotypes with those obtained using morpholino knockdown approaches can now be applied to confirm (or modify) the conclusions drawn from morpholino studies. Some of the diverging results between knockouts and knockdowns may tentatively also be explained by nonsense-mediated decay of mRNAs containing CRISPR/Cas9-generated premature stop codons, resulting in selective upregulation of genes with similar sequence.64,65 In this case, gene knockdown with morpholinos where no genetic compensation occurs may result in a more severe phenotype than knockout of the same gene.

Gene knockouts of the HS biosynthesis enzymes one by one or in combination would make it possible to generate a “living library” of fish or larva with different HS (or CS) structures for studies of both biosynthesis, gene function and pathology. In combination with single cell analysis techniques and advanced imaging techniques now available, there will be vast possibilities to increase our knowledge in the proteoglycan area.

Footnotes

Author Contributions: All authors contributed to the literature review and manuscript preparation.

Competing Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The research work performed by the authors was supported by The Swedish Cancer Society, SciLifeLab, and Stiftelsen för Proteoglykanforskning at Uppsala University.

Contributor Information

Beata Filipek-Górniok, Department of Organismal Biology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

Judith Habicher, Department of Neuroscience, Uppsala University, Uppsala, Sweden.

Johan Ledin, Department of Organismal Biology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

Lena Kjellén, Department of Medical Biochemistry and Microbiology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

Literature Cited

  • 1. Iozzo RV, Schaefer L. Proteoglycan form and function: a comprehensive nomenclature of proteoglycans. Matrix Biol. 2015;42:11–55. doi: 10.1016/j.matbio.2015.02.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Lindahl U, Couchman J, Kimata K, Esko JD. Proteoglycans and sulfated glycosaminoglycans. In: Varki A, Cummings RD, Esko JD, Stanley P, Hart GW, Aebi M, Darvill AG, Kinoshita T, Packer NH, Prestegard JH, Schnaar RL, Seeberger PH, editors. Essentials of glycobiology. New York: Cold Spring Harbor; 2015. p. 207–21. [Google Scholar]
  • 3. Toledo AG, Pihl J, Spliid CB, Persson A, Nilsson J, Pereira MA, Gustavsson T, Choudhary S, Oo HZ, Black PC, Daugaard M, Esko JD, Larson G, Salanti A, Clausen TM. An affinity-chromatography and glycoproteomics workflow to profile the chondroitin sulfate proteoglycans that interact with malarial VAR2CSA in the placenta and in cancer. Glycobiology. cwaa039, 10.1093/glycob/cwaa039 [DOI] [PMC free article] [PubMed]
  • 4. Poulain FE, Yost HJ. Heparan sulfate proteoglycans: a sugar code for vertebrate development? Development. 2015;142(20):3456–67. doi: 10.1242/dev.098178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Sarrazin S, Lamanna WC, Esko JD. Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol. 2011;3(7):1–33. doi: 10.1101/cshperspect.a004952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Kolset SO, Pejler G. Serglycin: a structural and functional chameleon with wide impact on immune cells. J Immunol. 2011;187(10):4927–33. doi: 10.4049/jimmunol.1100806. [DOI] [PubMed] [Google Scholar]
  • 7. Kjellen L, Lindahl U. Specificity of glycosaminoglycan-protein interactions. Curr Opin Struct Biol. 2018;50:101–8. doi: 10.1016/j.sbi.2017.12.011. [DOI] [PubMed] [Google Scholar]
  • 8. Lin X, Wei G, Shi Z, Dryer L, Esko JD, Wells DE, Matzuk MM. Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice. Dev Biol. 2000;224(2):299–311. doi: 10.1006/dbio.2000.9798. [DOI] [PubMed] [Google Scholar]
  • 9. Kreuger J, Kjellen L. Heparan sulfate biosynthesis: regulation and variability. J Histochem Cytochem. 2012;60(12):898–907. doi: 10.1369/0022155412464972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. El Masri R, Seffouh A, Lortat-Jacob H, Vives RR. The “in and out” of glucosamine 6-O-sulfation: the 6th sense of heparan sulfate. Glycoconj J. 2017;34(3):285–98. doi: 10.1007/s10719-016. [DOI] [PubMed] [Google Scholar]
  • 11. Gorsi B, Whelan S, Stringer SE. Dynamic expression patterns of 6-O endosulfatases during zebrafish development suggest a subfunctionalisation event for sulf2. Dev Dynam. 2010;239(12):3312–23. doi: 10.1002/dvdy.22456. [DOI] [PubMed] [Google Scholar]
  • 12. Glasauer SM, Neuhauss SC. Whole-genome duplication in teleost fishes and its evolutionary consequences. Mol Genet Genom. 2014;289(6):1045–60. doi: 10.1007/s00438-014. [DOI] [PubMed] [Google Scholar]
  • 13. Lindahl U, Kusche-Gullberg M, Kjellen L. Regulated diversity of heparan sulfate. J Biol Chem. 1998;273(39):24979–82. [DOI] [PubMed] [Google Scholar]
  • 14. Carlsson P, Presto J, Spillmann D, Lindahl U, Kjellen L. Heparin/heparan sulfate biosynthesis: processive formation of N-sulfated domains. J Biol Chem. 2008;283(29):20008–14. doi: 10.1074/jbc.M801652200. [DOI] [PubMed] [Google Scholar]
  • 15. Gallagher JT. Fell-Muir Lecture: heparan sulphate and the art of cell regulation: a polymer chain conducts the protein orchestra. Int J Exp Pathol. 2015;96:203–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Lee JS, von der Hardt S, Rusch MA, Stringer SE, Stickney HL, Talbot WS, Geisler R, Nusslein-Volhard C, Selleck SB, Chien CB, Roehl H. Axon sorting in the optic tract requires HSPG synthesis by ext2 (dackel) and extl3 (boxer). Neuron. 2004;44(6):947–60. doi: 10.1016/j.neuron.2004.11.029. [DOI] [PubMed] [Google Scholar]
  • 17. Holmborn K, Habicher J, Kasza Z, Eriksson AS, Filipek-Gorniok B, Gopal S, Couchman JR, Ahlberg PE, Wiweger M, Spillmann D, Kreuger J, Ledin J. On the roles and regulation of chondroitin sulfate and heparan sulfate in zebrafish pharyngeal cartilage morphogenesis. J Biol Chem. 2012;287(40):33905–16. doi: 10.1074/jbc.M112.401646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Gupta M, Brand M. Identification and expression analysis of zebrafish glypicans during embryonic development. PLoS ONE. 2013;8(11):e80824. doi: 10.1371/journal.pone.0080824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Zoeller JJ, McQuillan A, Whitelock J, Ho SY, Iozzo RV. A central function for perlecan in skeletal muscle and cardiovascular development. J Cell Biol. 2008;181(2):381–94. doi: 10.1083/jcb.200708022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Kim MJ, Liu IH, Song Y, Lee JA, Halfter W, Balice-Gordon RJ, Linney E, Cole GJ. Agrin is required for posterior development and motor axon outgrowth and branching in embryonic zebrafish. Glycobiology. 2007;17(2):231–47. doi: 10.1093/glycob/cwl069. [DOI] [PubMed] [Google Scholar]
  • 21. Banerjee S, Isaacman-Beck J, Schneider VA, Granato M. A novel role for Lh3 dependent ECM modifications during neural crest cell migration in zebrafish. PLoS ONE. 2013;8(1):e54609. doi: 10.1371/journal.pone.0054609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Jin H, Huang Z, Chi Y, Wu M, Zhou R, Zhao L, Xu J, Zhen F, Lan Y, Li L, Zhang W, Wen Z, Zhang Y. cMyb acts in parallel and cooperatively with Cebp1 to regulate neutrophil maturation in zebrafish. Blood. 2016;128(3):415–26. doi: 10.1182/blood-2015. [DOI] [PubMed] [Google Scholar]
  • 23. Li F, Shi W, Capurro M, Filmus J. Glypican-5 stimulates rhabdomyosarcoma cell proliferation by activating Hedgehog signaling. J Cell Biol. 2011;192(4):691–704. doi: 10.1083/jcb.201008087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Corti F, Wang Y, Rhodes JM, Atri D, Archer-Hartmann S, Zhang J, Zhuang ZW, Chen D, Wang T, Wang Z, Azadi P, Simons M. N-terminal syndecan-2 domain selectively enhances 6-O heparan sulfate chains sulfation and promotes VEGFA165-dependent neovascularization. Nat Commun. 2019;10(1):1562. doi: 10.1038/s41467-019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Mikami T, Kitagawa H. Biosynthesis and function of chondroitin sulfate. Biochim Biophys Acta. 2013;1830(10):4719–33. doi: 10.1016/j.bbagen.2013.06.006. [DOI] [PubMed] [Google Scholar]
  • 26. Koike T, Izumikawa T, Tamura J, Kitagawa H. FAM20B is a kinase that phosphorylates xylose in the glycosaminoglycan-protein linkage region. Biochem J. 2009;421(2):157–62. doi: 10.1042/BJ20090474. [DOI] [PubMed] [Google Scholar]
  • 27. Wen J, Xiao J, Rahdar M, Choudhury BP, Cui J, Taylor GS, Esko JD, Dixon JE. Xylose phosphorylation functions as a molecular switch to regulate proteoglycan biosynthesis. Proc Natl Acad Sci U S A. 2014;111(44):15723–8. doi: 10.1073/pnas.1417993111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Koike T, Izumikawa T, Sato B, Kitagawa H. Identification of phosphatase that dephosphorylates xylose in the glycosaminoglycan-protein linkage region of proteoglycans. J Biol Chem. 2014;289(10):6695–708. doi: 10.1074/jbc.M113.520536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Clement A, Wiweger M, von der Hardt S, Rusch MA, Selleck SB, Chien CB, Roehl HH. Regulation of zebrafish skeletogenesis by ext2/dackel and papst1/pinscher. PLoS Gen. 2008;4(7):e1000136. doi: 10.1371/journal.pgen.1000136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Hengel H, Bosso-Lefevre C, Grady G, Szenker-Ravi E, Li H, Pierce S, Lebigot E, Tan TT, Eio MY, Narayanan G, Utami KH, Yau M, Handal N, Deigendesch W, Keimer R, Marzouqa HM, Gunay-Aygun M, Muriello MJ, Verhelst H, Weckhuysen S, Mahida S, Naidu S, Thomas TG, Lim JY, Tan ES, Haye D, Willemsen M, Oegema R, Mitchell WG, Pierson TM, Andrews MV, Willing MC, Rodan LH, Barakat TS, van Slegtenhorst M, Gavrilova RH, Martinelli D, Gilboa T, Tamim AM, Hashem MO, AlSayed MD, Abdulrahim MM, Al-Owain M, Awaji A, Mahmoud AAH, Faqeih EA, Asmari AA, Algain SM, Jad LA, Aldhalaan HM, Helbig I, Koolen DA, Riess A, Kraegeloh-Mann I, Bauer P, Gulsuner S, Stamberger H, Ng AYJ, Tang S, Tohari S, Keren B, Schultz-Rogers LE, Klee EW, Barresi S, Tartaglia M, Mor-Shaked H, Maddirevula S, Begtrup A, Telegrafi A, Pfundt R, Schule R, Ciruna B, Bonnard C, Pouladi MA, Stewart JC, Claridge-Chang A, Lefeber DJ, Alkuraya FS, Mathuru AS, Venkatesh B, Barycki JJ, Simpson MA, Jamuar SS, Schols L, Reversade B. Loss-of-function mutations in UDP-Glucose 6-Dehydrogenase cause recessive developmental epileptic encephalopathy. Nat Commun. 2020;11(1):595. doi: 10.1038/s41467-020-14360-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Garcia-Garcia MJ, Anderson KV. Essential role of glycosaminoglycans in Fgf signaling during mouse gastrulation. Cell. 2003;114(6):727–37. doi: 10.1016/s0092-8674(03)00715-3. [DOI] [PubMed] [Google Scholar]
  • 32. Walsh EC, Stainier DY. UDP-glucose dehydrogenase required for cardiac valve formation in zebrafish. Science. 2001;293(5535):1670–3. doi: 10.1126/science.293.5535.1670. [DOI] [PubMed] [Google Scholar]
  • 33. Superina S, Borovina A, Ciruna B. Analysis of maternal-zygotic ugdh mutants reveals divergent roles for HSPGs in vertebrate embryogenesis and provides new insight into the initiation of left-right asymmetry. Dev Biol. 2014;387(2):154–66. doi: 10.1016/j.ydbio.2014.01.013. [DOI] [PubMed] [Google Scholar]
  • 34. Blake JA, Bult CJ, Eppig JT, Kadin JA, Richardson JE, Mouse Genome Database G. The Mouse Genome Database: integration of and access to knowledge about the laboratory mouse. Nucleic Acids Res. 2014;42(Database issue):D810–7. doi: 10.1093/nar/gkt1225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Eames BF, Singer A, Smith GA, Wood ZA, Yan YL, He X, Polizzi SJ, Catchen JM, Rodriguez-Mari A, Linbo T, Raible DW, Postlethwait JH. UDP xylose synthase 1 is required for morphogenesis and histogenesis of the craniofacial skeleton. Dev Biol. 2010;341(2):400–15. doi: 10.1016/j.ydbio.2010.02.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Elsik CG, Tellam RL, Worley KC, Gibbs RA, Muzny DM, Weinstock GM, Adelson DL, Eichler EE, Elnitski L, Guigo R, Hamernik DL, Kappes SM, Lewin HA, Lynn DJ, Nicholas FW, Reymond A, Rijnkels M, Skow LC, Zdobnov EM, Schook L, Womack J, Alioto T, Antonarakis SE, Astashyn A, Chapple CE, Chen HC, Chrast J, Camara F, Ermolaeva O, Henrichsen CN, Hlavina W, Kapustin Y, Kiryutin B, Kitts P, Kokocinski F, Landrum M, Maglott D, Pruitt K, Sapojnikov V, Searle SM, Solovyev V, Souvorov A, Ucla C, Wyss C, Anzola JM, Gerlach D, Elhaik E, Graur D, Reese JT, Edgar RC, McEwan JC, Payne GM, Raison JM, Junier T, Kriventseva EV, Eyras E, Plass M, Donthu R, Larkin DM, Reecy J, Yang MQ, Chen L, Cheng Z, Chitko-McKown CG, Liu GE, Matukumalli LK, Song J, Zhu B, Bradley DG, Brinkman FS, Lau LP, Whiteside MD, Walker A, Wheeler TT, Casey T, German JB, Lemay DG, Maqbool NJ, Molenaar AJ, Seo S, Stothard P, Baldwin CL, Baxter R, Brinkmeyer-Langford CL, Brown WC, Childers CP, Connelley T, Ellis SA, Fritz K, Glass EJ, Herzig CT, Iivanainen A, Lahmers KK, Bennett AK, Dickens CM, Gilbert JG, Hagen DE, Salih H, Aerts J, Caetano AR, Dalrymple B, Garcia JF, Gill CA, Hiendleder SG, Memili E, Spurlock D, Williams JL, Alexander L, Brownstein MJ, Guan L, Holt RA, Jones SJ, Marra MA, Moore R, Moore SS, Roberts A, Taniguchi M, Waterman RC, Chacko J, Chandrabose MM, Cree A, Dao MD, Dinh HH, Gabisi RA, Hines S, Hume J, Jhangiani SN, Joshi V, Kovar CL, Lewis LR, Liu YS, Lopez J, Morgan MB, Nguyen NB, Okwuonu GO, Ruiz SJ, Santibanez J, Wright RA, Buhay C, Ding Y, Dugan-Rocha S, Herdandez J, Holder M, Sabo A, Egan A, Goodell J, Wilczek-Boney K, Fowler GR, Hitchens ME, Lozado RJ, Moen C, Steffen D, Warren JT, Zhang J, Chiu R, Schein JE, Durbin KJ, Havlak P, Jiang H, Liu Y, Qin X, Ren Y, Shen Y, Song H, Bell SN, Davis C, Johnson AJ, Lee S, Nazareth LV, Patel BM, Pu LL, Vattathil S, Williams RL, Jr, Curry S, Hamilton C, Sodergren E, Wheeler DA, Barris W, Bennett GL, Eggen A, Green RD, Harhay GP, Hobbs M, Jann O, Keele JW, Kent MP, Lien S, McKay SD, McWilliam S, Ratnakumar A, Schnabel RD, Smith T, Snelling WM, Sonstegard TS, Stone RT, Sugimoto Y, Takasuga A, Taylor JF, Van Tassell CP, Macneil MD, Abatepaulo AR, Abbey CA, Ahola V, Almeida IG, Amadio AF, Anatriello E, Bahadue SM, Biase FH, Boldt CR, Carroll JA, Carvalho WA, Cervelatti EP, Chacko E, Chapin JE, Cheng Y, Choi J, Colley AJ, de Campos TA, De Donato M, Santos IK, de Oliveira CJ, Deobald H, Devinoy E, Donohue KE, Dovc P, Eberlein A, Fitzsimmons CJ, Franzin AM, Garcia GR, Genini S, Gladney CJ, Grant JR, Greaser ML, Green JA, Hadsell DL, Hakimov HA, Halgren R, Harrow JL, Hart EA, Hastings N, Hernandez M, Hu ZL, Ingham A, Iso-Touru T, Jamis C, Jensen K, Kapetis D, Kerr T, Khalil SS, Khatib H, Kolbehdari D, Kumar CG, Kumar D, Leach R, Lee JC, Li C, Logan KM, Malinverni R, Marques E, Martin WF, Martins NF, Maruyama SR, Mazza R, McLean KL, Medrano JF, Moreno BT, More DD, Muntean CT, Nandakumar HP, Nogueira MF, Olsaker I, Pant SD, Panzitta F, Pastor RC, Poli MA, Poslusny N, Rachagani S, Ranganathan S, Razpet A, Riggs PK, Rincon G, Rodriguez-Osorio N, Rodriguez-Zas SL, Romero NE, Rosenwald A, Sando L, Schmutz SM, Shen L, Sherman L, Southey BR, Lutzow YS, Sweedler JV, Tammen I, Telugu BP, Urbanski JM, Utsunomiya YT, Verschoor CP, Waardenberg AJ, Wang Z, Ward R, Weikard R, Welsh TH, Jr., White SN, Wilming LG, Wunderlich KR, Yang J, Zhao FQ. The genome sequence of taurine cattle: a window to ruminant biology and evolution. Science. 2009;324(5926):522–8. doi: 10.1126/science.1169588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Vogel P, Hansen GM, Read RW, Vance RB, Thiel M, Liu J, Wronski TJ, Smith DD, Jeter-Jones S, Brommage R. Amelogenesis imperfecta and other biomineralization defects in Fam20a and Fam20c null mice. Vet Pathol. 2012;49(6):998–1017. doi: 10.1177/0300985812453177. [DOI] [PubMed] [Google Scholar]
  • 38. Saiyin W, Li L, Zhang H, Lu Y, Qin C. Inactivation of FAM20B causes cell fate changes in annulus fibrosus of mouse intervertebral disc and disc defects via the alterations of TGF-beta and MAPK signaling pathways. Biochim Biophys Acta Mol Basis Dis. 2019;1865(12):165555. doi: 10.1016/j.bbadis.2019.165555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Eames BF, Yan YL, Swartz ME, Levic DS, Knapik EW, Postlethwait JH, Kimmel CB. Mutations in fam20b and xylt1 reveal that cartilage matrix controls timing of endochondral ossification by inhibiting chondrocyte maturation. PLoS Genet. 2011;7(8):e1002246. doi: 10.1371/journal.pgen.1002246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Bui C, Huber C, Tuysuz B, Alanay Y, Bole-Feysot C, Leroy JG, Mortier G, Nitschke P, Munnich A, Cormier-Daire V. XYLT1 mutations in Desbuquois dysplasia type 2. Am J Human Genet. 2014;94(3):405–14. doi: 10.1016/j.ajhg.2014.01.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Quentin E, Gladen A, Roden L, Kresse H. A genetic defect in the biosynthesis of dermatan sulfate proteoglycan: galactosyltransferase I deficiency in fibroblasts from a patient with a progeroid syndrome. Proc Natl Acad Sci U S A. 1990;87(4):1342–6. doi: 10.1073/pnas.87.4.1342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Amsterdam A, Nissen RM, Sun Z, Swindell EC, Farrington S, Hopkins N. Identification of 315 genes essential for early zebrafish development. Proc Natl Acad Sci U S A. 2004;101(35):12792–7. doi: 10.1073/pnas.0403929101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Nissen RM, Amsterdam A, Hopkins N. A zebrafish screen for craniofacial mutants identifies wdr68 as a highly conserved gene required for endothelin-1 expression. BMC Dev Biol. 2006;6:28. doi: 10.1186/1471-213X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Delbaere S, Van Damme T, Syx D, Symoens S, Coucke P, Willaert A, Malfait F. Hypomorphic zebrafish models mimic the musculoskeletal phenotype of beta4GalT7-deficient Ehlers-Danlos syndrome. Matrix Biol. 2020;89:59–75. doi: 10.1016/j.matbio.2019.12.002. [DOI] [PubMed] [Google Scholar]
  • 45. Wiweger MI, Avramut CM, de Andrea CE, Prins FA, Koster AJ, Ravelli RB, Hogendoorn PC. Cartilage ultrastructure in proteoglycan-deficient zebrafish mutants brings to light new candidate genes for human skeletal disorders. J Pathol. 2011;223(4):531–42. doi: 10.1002/path.2824. [DOI] [PubMed] [Google Scholar]
  • 46. Takahashi I, Noguchi N, Nata K, Yamada S, Kaneiwa T, Mizumoto S, Ikeda T, Sugihara K, Asano M, Yoshikawa T, Yamauchi A, Shervani NJ, Uruno A, Kato I, Unno M, Sugahara K, Takasawa S, Okamoto H, Sugawara A. Important role of heparan sulfate in postnatal islet growth and insulin secretion. Biochem Biophys Res Commun. 2009;383(1):113–8. doi: 10.1016/j.bbrc.2009.03.140. [DOI] [PubMed] [Google Scholar]
  • 47. Schilling TF, Piotrowski T, Grandel H, Brand M, Heisenberg CP, Jiang YJ, Beuchle D, Hammerschmidt M, Kane DA, Mullins MC, van Eeden FJ, Kelsh RN, Furutani-Seiki M, Granato M, Haffter P, Odenthal J, Warga RM, Trowe T, Nusslein-Volhard C. Jaw and branchial arch mutants in zebrafish I: branchial arches. Development. 1996;123:329–44. [DOI] [PubMed] [Google Scholar]
  • 48. Stickens D, Zak BM, Rougier N, Esko JD, Werb Z. Mice deficient in Ext2 lack heparan sulfate and develop exostoses. Development. 2005;132(22):5055–68. doi: 10.1242/dev.02088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Wiweger MI, Zhao Z, van Merkesteyn RJ, Roehl HH, Hogendoorn PC. HSPG-deficient zebrafish uncovers dental aspect of multiple osteochondromas. PLoS ONE. 2012;7(1):e29734. doi: 10.1371/journal.pone.0029734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Noborn F, Gomez Toledo A, Green A, Nasir W, Sihlbom C, Nilsson J, Larson G. Site-specific identification of heparan and chondroitin sulfate glycosaminoglycans in hybrid proteoglycans. Sci Rep. 2016;6:34537. doi: 10.1038/srep34537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Nadanaka S, Zhou S, Kagiyama S, Shoji N, Sugahara K, Sugihara K, Asano M, Kitagawa H. EXTL2, a member of the EXT family of tumor suppressors, controls glycosaminoglycan biosynthesis in a xylose kinase-dependent manner. J Biol Chem. 2013;288(13):9321–33. doi: 10.1074/jbc.M112.416909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Filipek-Gorniok B, Carlsson P, Haitina T, Habicher J, Ledin J, Kjellen L. The NDST gene family in zebrafish: role of ndst1b in pharyngeal arch formation. PLoS ONE. 2015;10(3):e0119040. doi: 10.1371/journal.pone.0119040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Cadwallader AB, Yost HJ. Combinatorial expression patterns of heparan sulfate sulfotransferases in zebrafish: III. 2-O-sulfotransferase and C5-epimerases. Dev Dynam. 2007;236(2):581–6. doi: 10.1002/dvdy.21051. [DOI] [PubMed] [Google Scholar]
  • 54. Cadwallader AB, Yost HJ. Combinatorial expression patterns of heparan sulfate sulfotransferases in zebrafish: II. The 6-O-sulfotransferase family. Dev Dynam. 2006;235(12):3432–7. doi: 10.1002/dvdy.20990. [DOI] [PubMed] [Google Scholar]
  • 55. Cadwallader AB, Yost HJ. Combinatorial expression patterns of heparan sulfate sulfotransferases in zebrafish: I. The 3-O-sulfotransferase family. Deve Dynam. 2006;235(12):3423–31. doi: 10.1002/dvdy.20991. [DOI] [PubMed] [Google Scholar]
  • 56. Habicher J, Filipek-Górniok B, Kjellén L, Ledin J. Proteoglycans in zebrafish development. In: Götte M, Forsberg-Nilsson K, editors. Proteoglycans in stem cells: from development to cancer. Springer nature series biology of the extracellular matrix. in press. [Google Scholar]
  • 57. Norton WH, Ledin J, Grandel H, Neumann CJ. HSPG synthesis by zebrafish Ext2 and Extl3 is required for Fgf10 signalling during limb development. Development. 2005;132(22):4963–73. doi: 10.1242/dev.02084. [DOI] [PubMed] [Google Scholar]
  • 58. Volpi S, Yamazaki Y, Brauer PM, van Rooijen E, Hayashida A, Slavotinek A, Sun Kuehn H, Di Rocco M, Rivolta C, Bortolomai I, Du L, Felgentreff K, Ott de, Bruin L, Hayashida K, Freedman G, Marcovecchio GE, Capuder K, Rath P, Luche N, Hagedorn EJ, Buoncompagni A, Royer-Bertrand B, Giliani S, Poliani PL, Imberti L, Dobbs K, Poulain FE, Martini A, Manis J, Linhardt RJ, Bosticardo M, Rosenzweig SD, Lee H, Puck JM, Zuniga-Pflucker JC, Zon L, Park PW, Superti-Furga A, Notarangelo LD. EXTL3 mutations cause skeletal dysplasia, immune deficiency, and developmental delay. J Exp Med. 2017;214(3):623–37. doi: 10.1084/jem.20161525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Lidholt K, Weinke JL, Kiser CS, Lugemwa FN, Bame KJ, Cheifetz S, Massague J, Lindahl U, Esko JD. A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis. Proc Natl Acad Sci U S A. 1992;89(6):2267–71. doi: 10.1073/pnas.89.6.2267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Le Jan S, Hayashi M, Kasza Z, Eriksson I, Bishop JR, Weibrecht I, Heldin J, Holmborn K, Jakobsson L, Soderberg O, Spillmann D, Esko JD, Claesson-Welsh L, Kjellen L, Kreuger J. Functional overlap between chondroitin and heparan sulfate proteoglycans during VEGF-induced sprouting angiogenesis. Arterioscler Thromb Vasc Biol. 2012;32(5):1255–63. doi: 10.1161/ATVBAHA.111.240622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Bachvarova V, Dierker T, Esko J, Hoffmann D, Kjellen L, Vortkamp A. Chondrocytes respond to an altered heparan sulfate composition with distinct changes of heparan sulfate structure and increased levels of chondroitin sulfate. Matrix Biol. Epub ahead of print March 2020. doi: 10.1016/j.matbio.2020.03.006. [DOI] [PubMed] [Google Scholar]
  • 62. Stainier DYR, Raz E, Lawson ND, Ekker SC, Burdine RD, Eisen JS, Ingham PW, Schulte-Merker S, Yelon D, Weinstein BM, Mullins MC, Wilson SW, Ramakrishnan L, Amacher SL, Neuhauss SCF, Meng A, Mochizuki N, Panula P, Moens CB. Guidelines for morpholino use in zebrafish. PLoS Genet. 2017;13(10):e1007000. doi: 10.1371/journal.pgen.1007000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Rissone A, Ledin J, Burgess S. Targeted editing of zebrafish genes to understand gene function and human disease pathology. In: Cartner SC, Eisen JS, Farmer SC, Guillemin KJ, Kent ML, Sanders GE, editors. The zebrafish in biomedical research: biology, husbandry, diseases and research applications. Cambridge: Academic Press; 2020. p. 637–47. [Google Scholar]
  • 64. Rossi A, Kontarakis Z, Gerri C, Nolte H, Holper S, Kruger M, Stainier DY. Genetic compensation induced by deleterious mutations but not gene knockdowns. Nature. 2015;524(7564):230–3. doi: 10.1038/nature14580. [DOI] [PubMed] [Google Scholar]
  • 65. El-Brolosy MA, Kontarakis Z, Rossi A, Kuenne C, Gunther S, Fukuda N, Kikhi K, Boezio GLM, Takacs CM, Lai SL, Fukuda R, Gerri C, Giraldez AJ, Stainier DYR. Genetic compensation triggered by mutant mRNA degradation. Nature. 2019;568(7751):193–7. doi: 10.1038/s41586-019-1064-z. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Histochemistry and Cytochemistry are provided here courtesy of The Histochemical Society

RESOURCES